BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28669898)

  • 21. Calcium Channelopathies: Structural Insights into Disorders of the Muscle Excitation-Contraction Complex.
    Pancaroglu R; Van Petegem F
    Annu Rev Genet; 2018 Nov; 52():373-396. PubMed ID: 30208288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic neurological channelopathies.
    Hanna MG
    Nat Clin Pract Neurol; 2006 May; 2(5):252-63. PubMed ID: 16932562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmune channelopathies in paraneoplastic neurological syndromes.
    Joubert B; Honnorat J
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological channelopathies.
    Kullmann DM
    Annu Rev Neurosci; 2010; 33():151-72. PubMed ID: 20331364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-translational dysfunctions in channelopathies of the nervous system.
    Terragni B; Scalmani P; Franceschetti S; Cestèle S; Mantegazza M
    Neuropharmacology; 2018 Apr; 132():31-42. PubMed ID: 28571716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision physiology and rescue of brain ion channel disorders.
    Noebels J
    J Gen Physiol; 2017 May; 149(5):533-546. PubMed ID: 28428202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits.
    McKeown L; Robinson P; Jones OT
    Acta Pharmacol Sin; 2006 Jul; 27(7):799-812. PubMed ID: 16787562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ion channelopathies in functional GI disorders.
    Beyder A; Farrugia G
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G581-G586. PubMed ID: 27514480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired neuronal channelopathies in HIV-associated dementia.
    Gelman BB; Soukup VM; Schuenke KW; Keherly MJ; Holzer C; Richey FJ; Lahart CJ
    J Neuroimmunol; 2004 Dec; 157(1-2):111-9. PubMed ID: 15579287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.
    Imbrici P; Liantonio A; Camerino GM; De Bellis M; Camerino C; Mele A; Giustino A; Pierno S; De Luca A; Tricarico D; Desaphy JF; Conte D
    Front Pharmacol; 2016; 7():121. PubMed ID: 27242528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic generalized epilepsy and hypokalemic periodic paralysis in a family of South Indian descent.
    Subramanian M; Senthil N; Sujatha S
    Case Rep Neurol Med; 2015; 2015():906049. PubMed ID: 25893123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
    Horvath GA; Demos M; Shyr C; Matthews A; Zhang L; Race S; Stockler-Ipsiroglu S; Van Allen MI; Mancarci O; Toker L; Pavlidis P; Ross CJ; Wasserman WW; Trump N; Heales S; Pope S; Cross JH; van Karnebeek CD
    Mol Genet Metab; 2016 Jan; 117(1):42-8. PubMed ID: 26647175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Ion Channels in Functional Gastrointestinal Disorders (FGID): Evidence of Channelopathies and Potential Avenues for Future Research and Therapeutic Targets.
    Maqoud F; Tricarico D; Mallamaci R; Orlando A; Russo F
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into channel dysfunction from modelling and molecular dynamics simulations.
    Musgaard M; Paramo T; Domicevica L; Andersen OJ; Biggin PC
    Neuropharmacology; 2018 Apr; 132():20-30. PubMed ID: 28669899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathomechanisms in channelopathies of skeletal muscle and brain.
    Cannon SC
    Annu Rev Neurosci; 2006; 29():387-415. PubMed ID: 16776591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early infantile epileptic encephalopathy associated with a high voltage gated calcium channelopathy.
    Edvardson S; Oz S; Abulhijaa FA; Taher FB; Shaag A; Zenvirt S; Dascal N; Elpeleg O
    J Med Genet; 2013 Feb; 50(2):118-23. PubMed ID: 23339110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological channelopathies: diagnosis and therapy in the new millennium.
    Davies NP; Hanna MG
    Ann Med; 1999 Dec; 31(6):406-20. PubMed ID: 10680855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders.
    Lory P; Mezghrani A
    IDrugs; 2010 Jul; 13(7):467-71. PubMed ID: 20582871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ca2+ Channels in Anterior Pituitary Somatotrophs: A Therapeutic Perspective.
    Nussinovitch I
    Endocrinology; 2018 Dec; 159(12):4043-4055. PubMed ID: 30395240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.